1 / 15

The Psychosocial Impact of Testing Individuals with No Prior History of Genital Herpes for Herpes Simplex Virus Type 2

Background. CDC Prevention Agenda for Genital HerpesAssess the psychosocial impact of HSV serologic diagnosis among persons with no history of genital herpesHSV-2 serologic testing at STD Clinic began in May 2000 Clinicians initially concerned about psychosocial impact. Study Objectives. To measu

saxon
Download Presentation

The Psychosocial Impact of Testing Individuals with No Prior History of Genital Herpes for Herpes Simplex Virus Type 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. The Psychosocial Impact of Testing Individuals with No Prior History of Genital Herpes for Herpes Simplex Virus Type 2 KR Turner, T Miyai, CK Kent, JD Klausner STD Prevention and Control Services, San Francisco Department of Public Health

    2. Background CDC Prevention Agenda for Genital Herpes Assess the psychosocial impact of HSV serologic diagnosis among persons with no history of genital herpes HSV-2 serologic testing at STD Clinic began in May 2000 Clinicians initially concerned about psychosocial impact

    3. Study Objectives To measure changes in perception of trauma associated with genital herpes To measure changes in general mental health and wellbeing following serologic HSV-2 testing To measure changes in sexual attitudes following serologic HSV-2 testing To evaluate the impact a positive HSV-2 result had on quality of life

    4. Study Design Prospective cohort study Participants: patients attending STD Clinic between April and August 2001 who expressed interest in HSV-2 testing and had no prior diagnosis of genital herpes

    5. Measures of psychosocial morbidity: Genital herpes trauma score (ASHA) Adjusted Rand Mental Health Inventory 5 item version Adapted Multidimensional Sexual Self-Concept Questionnaire (Snell) Herpes Quality of Life (HQoL) questionnaire among HSV-2 infected (Galen)

    6. Data analysis: Compared the mean scores at baseline to mean scores at follow-up by HSV-2 status. Quality of Life scores among HSV-2 positives at Follow-Up interviews Odds ratios, 95% confidence intervals, and Chi Square tests for significance were calculated

    14. Limitations Sample size Follow-up rate Sensitivity of questionnaires

    15. Conclusions and Recommendations No significant differences in psychosocial morbidity by HSV-2 status in this population Psychosocial morbidity should not be a barrier to testing for HSV-2

    16. Acknowledgements San Francisco STD Prevention and Control Services: Tomio Miyai SFCC Clinicians SFCC DCIs and Health Educators Joe Catania, UCSF Galen Research for HQoL ASHA for questions about perception of trauma

More Related